Notice of Intention to make an award under the Most Suitable Provider (MSP) process - Provision of end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting services

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2027-03-13T23:59:59Z",
        "maxExtentDate": "2028-03-13T23:59:59Z",
        "startDate": "2026-03-13T00:00:00Z"
      },
      "documents": [
        {
          "datePublished": "2026-02-26T12:56:48Z",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "017292-2026",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/017292-2026"
        }
      ],
      "hasRenewal": true,
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Pathology services",
              "id": "85111800",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "services",
      "milestones": [
        {
          "dueDate": "2026-03-13T23:59:59Z",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "renewal": {
        "description": "12 months possible extension"
      },
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-COH-15997568",
          "name": "Inify Laboratories Ltd"
        }
      ],
      "title": "Provision of end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting",
      "value": {
        "amount": 275000.0,
        "amountGross": 275000.0,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PWJW-1642-HQRM",
    "name": "University Hospitals Plymouth"
  },
  "date": "2026-02-26T12:56:48Z",
  "id": "017292-2026",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-065cfc",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Plymouth",
        "postalCode": "PL6 8DH",
        "region": "UKK41",
        "streetAddress": "Derriford Road"
      },
      "contactPoint": {
        "email": "m.austin2@nhs.net",
        "name": "Mark Austin",
        "telephone": "01752430312"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.plymouthhospitals.nhs.uk/"
      },
      "id": "GB-PPON-PWJW-1642-HQRM",
      "identifier": {
        "id": "PWJW-1642-HQRM",
        "scheme": "GB-PPON"
      },
      "name": "University Hospitals Plymouth",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Oxford",
        "postalCode": "OX14 4SE",
        "region": "UKJ14",
        "streetAddress": "191C  Nebula Park Drive  Milton Park  Oxfordshire"
      },
      "contactPoint": {
        "email": "sophie.holt@inify.com",
        "telephone": "07528403820"
      },
      "details": {
        "scale": "large",
        "vcse": false
      },
      "id": "GB-COH-15997568",
      "identifier": {
        "id": "15997568",
        "scheme": "GB-COH"
      },
      "name": "Inify Laboratories Ltd",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "1. This is a Provider Selection Regime (PSR) Notice of Intention to make an award. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. \nThis is a Notice of Intention to make an award and is being published in line with Regulation 12 - under The Health Care Services (Provider Selection Regime - PSR) Regulations 2023. The Most Suitable Provider Process shall be used to commission this service and award a contract.\n2. The contract title and Reference -\nProvision of end-to-end digital histopathology pathway service with\nintegrated AI diagnostic support and NHS reporting\nThe contract reference - C407455\n3. The name and address of the registered office or principal place of business of the provider to whom the contract has been awarded - \nInify Laboratories Ltd\n191c Nebula\nPark Drive\nMilton Park\nOxfordshire\nEngland\nOX14 4SE\n4. A description of the relevant health care services to which the contract relates, including the most relevant CPV code - \nInify delivers a fully integrated, co-designed diagnostic service that aligns with NHS pathways, enables seamless information sharing, and strengthens multidisciplinary collaboration. Its resilient, scalable, and digitally enabled model ensures long-term service continuity and robust governance\n85111800 - Pathology services\n5. The lifetime value of the contract or, where it is not known, the amounts payable to the provider under the contract - \n\u00a3275000\n6. Details of the award decision-makers - \nRob Archer (Cellular \u0026 Anatomical Pathology Operations Manager), Mark Austin (Category Manager for Clinical Support)\n7.  A statement explaining the award decision-makers\u2019 reasons for selecting the chosen provider, with reference to the key criteria - \nBased on our assessment against PSR criteria, we believe Inify Laboratories is the only provider capable of delivering the required service for the following reasons:\n\u2022 End-to-End Integrated Diagnostic Pathway: Inify offers a fully digital, AI-supported histopathology service covering the entire prostate cancer diagnostic workflow\u2014from biopsy logistics to final reporting\u2014within a unified digital ecosystem.\n\u2022 Immediate Access to a Complete Digital Solution: Their platform is fully paperless and interoperable from day one, regardless of the Trust\u2019s existing digital infrastructure.\n\u2022 Specialist Focus and Proven Expertise: Inify is purpose-built for prostate cancer diagnostics, with 2.5 years of proven experience in Sweden, delivering faster and more accurate diagnoses compared to generalist labs.\n\u2022 AI-Enhanced Accuracy and Efficiency: Validated AI tools significantly reduce diagnostic variation and improve turnaround times (average 3.5 days), supporting NHS reporting targets.\n\u2022 ISO 15189 Accredited Digital Lab: Inify operates a fully standardised, controlled laboratory with embedded AI and an in-house LIMS, ensuring quality and compliance at scale.\n\u2022 Alignment with NHS Objectives: The service directly supports the NHS Histopathology Improvement Plan and National Cancer reporting targets, while improving workforce efficiency and patient experience\n8. Any declared conflicts or potential conflicts of interest - \nNo declared conflicts of interest\n9. Information as to how any conflicts or potential conflicts of interest were managed - \nDecision makers have completed and signed conflicts of interest declarations prior to commencing the process (no conflicts declared).",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "ocds-h6vhtk-065cfc",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "This intention to award notice is being conducted via most suitable provider route",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersUniqueWorkArtPerformance"
      },
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "status": "complete",
    "title": "Notice of Intention to make an award under the Most Suitable Provider (MSP) process - Provision of end-to-end digital histopathology pathway service with integrated AI diagnostic support and NHS reporting services"
  }
}